Investors
We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.
First Quarter 2025
First quarter 2025 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Thursday April 24, 2025
Press Releases
June 5, 2025
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan
June 3, 2025
Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector
June 3, 2025
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Upcoming Events
4Jun
2025
10Jun
2025
19Jun
2025
JPM European Healthcare Forum
08:00 - 15:00 GMT (London)
Conferences
30th Consecutive Year of Dividend Increase
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00